Personalizing lymphoma treatment: New study seeks better outcomes
A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.
Read Article
-
-
From patient to volunteer: Marge’s gift of gratitude
Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.
Read Article
-
Reflecting on 2025, building toward 2026
Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
Read Article
-
Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection
Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.
Read Article
-
A precision oncology revolution is underway at Providence
Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.
Read Article
-
2025 SITC Meeting: Three Providence researchers honored at 40th anniversary
Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.
Read Article
-
Oncology Lecture Series: The state of lung cancer screening and thoracic robotic surgery with Dr. Areo Saffarzadeh
Thoracic surgeon and director of Robotic Thoracic Surgery at Providence Cancer Institute shares the latest in lung cancer screening and treatment approaches.
Read Article
-
Transforming outcomes in AML and breast cancer: Three open trials at Providence
New studies at Providence Cancer Institute offer hope to patients with limited treatment options.
Read Article
-
Oregon cancer leaders unite to discuss research and policy
Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.
Read Article
-
Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.
Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.
Read Article
-
Next generation therapy for men with mCRPC may extend survival
A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.
Read Article
-
Behind the science: Celebrating our cancer research administrator
Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.
Read Article
-
Charting new paths in treating ovarian cancer and recurring SCLC
Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.
Read Article
-
The future of surgery is robotic, and it’s here
Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.
Read Article
-
Meet the 2025 cancer research interns
Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.
Read Article
-
Watch: Virtual health talk on understanding lung cancer
Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.
Read Article
-
A new cancer therapy at Providence helps immune cells stand their ground
A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.
Read Article
-
A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.
Read Article
-
Cancer patients in Newberg receive a gift of comfort
A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.
Read Article
-
New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research
Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.
Read Article
-
Loading More...
